E261K (p.Glu261Lys) variant of SGCD (Delta-sarcoglycan)

E261K (p.Glu261Lys) in SGCD (Delta-sarcoglycan) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely pathogenic in the context of Autosomal recessive limb-girdle muscular dystrophy type 2F; Dilated cardiomyopat. The available variant effect predictions contribute to a CATVariant prioritization score of 0.76 / 1. The record also includes population frequency data, published literature, and structural context.

E261K (p.Glu261Lys) variant details